Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (131-140 of 471) with videos related to

Pageof 48
Sort By:
Health Science Reports|June 22, 2026
Time-Related Burden of Treatment With Parenterally Administered Complement Inhibitors: A Mixed Methods Observational Study Exploring Experiences among Patients With Paroxysmal Nocturnal HemoglobinuriaDavid Dingli, Lynne Broderick, Avery A Rizio, et al.
Mayo Clinic Proceedings|January 7, 2018
Safety Outcomes for Autologous Stem Cell Transplant in Multiple MyelomaMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Cancer Medicine|December 21, 2025
Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse EventsMavis Obeng-Kusi, Enrico De Nigris, Siyang Leng, et al.
Transplantation and Cellular Therapy|May 18, 2026
Dynamic-EASIX DRI model: a novel tool for predicting outcomes after allogeneic hematopoietic cell transplantationAnmol Baranwal, Rabee Kassis, Khalil Hassan, et al.
American Journal of Hematology|October 17, 2020
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantationIuliana Vaxman, Alissa Visram, Prashant Kapoor, et al.
Transplantation and Cellular Therapy|June 21, 2021
The Efficacy and Safety of Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma Patients Who Are Poor Responders to Induction: The Mayo Clinic ExperienceIuliana Vaxman, Eli Muchtar, Eapen Jacob, et al.
Leukemia & Lymphoma|May 13, 2022
Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantationMorie A Gertz, Rahma Warsame, Eli Muchtar, et al.
Cancer Research|August 2, 2014
Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemiaBenjamin Werner, Robert E Gallagher, Elisabeth M Paietta, et al.
Cancer|October 20, 2011
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myelomaShaji K Kumar, Martha Q Lacy, Angela Dispenzieri, et al.
Leukemia & Lymphoma|July 9, 2016
Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myelomaRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
Pageof 48

Showing results (131-140 of 471) with videos related to

Sort By:
Pageof 48
Health Science Reports|June 22, 2026
Time-Related Burden of Treatment With Parenterally Administered Complement Inhibitors: A Mixed Methods Observational Study Exploring Experiences among Patients With Paroxysmal Nocturnal HemoglobinuriaDavid Dingli, Lynne Broderick, Avery A Rizio, et al.
Mayo Clinic Proceedings|January 7, 2018
Safety Outcomes for Autologous Stem Cell Transplant in Multiple MyelomaMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Cancer Medicine|December 21, 2025
Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse EventsMavis Obeng-Kusi, Enrico De Nigris, Siyang Leng, et al.
Transplantation and Cellular Therapy|May 18, 2026
Dynamic-EASIX DRI model: a novel tool for predicting outcomes after allogeneic hematopoietic cell transplantationAnmol Baranwal, Rabee Kassis, Khalil Hassan, et al.
American Journal of Hematology|October 17, 2020
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantationIuliana Vaxman, Alissa Visram, Prashant Kapoor, et al.
Transplantation and Cellular Therapy|June 21, 2021
The Efficacy and Safety of Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma Patients Who Are Poor Responders to Induction: The Mayo Clinic ExperienceIuliana Vaxman, Eli Muchtar, Eapen Jacob, et al.
Leukemia & Lymphoma|May 13, 2022
Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantationMorie A Gertz, Rahma Warsame, Eli Muchtar, et al.
Cancer Research|August 2, 2014
Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemiaBenjamin Werner, Robert E Gallagher, Elisabeth M Paietta, et al.
Cancer|October 20, 2011
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myelomaShaji K Kumar, Martha Q Lacy, Angela Dispenzieri, et al.
Leukemia & Lymphoma|July 9, 2016
Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myelomaRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
Pageof 48